Farmacoriflessioni
Uso degli alfa-antagonisti nella calcolosi renale in età pediatrica: quali evidenze?
Use of alpha-antagonist in the treatment of kidney stones in paediatric age: what evidence?
Ludovica Facchini*, Sara Pusceddu, Luca Casadio, Federico Marchetti
UOC di Pediatria e Neonatologia, Ospedale di Ravenna, AUSL della Romagna
*Scuola di Specializzazione in Pediatria, Università di Ferrara
Settembre 2019 - pagg. 445 -448
Abstract
Alpha-antagonists as an expulsive therapy for ureteral stones are widely recognized in
adults. On the basis of the evidence in the literature, in children/adolescents with a kidney
stone < 12 mm after the failure of the conventional therapy (hydration and painkilling
therapy), it is possible to use alpha-antagonists to favour the expulsion of the stone
in shorter time. This class of drugs has not shown important side effects, however clinical
records are very few in Paediatrics. At the moment the level of this recommendation is
low, therefore clinical randomised multicentric studies are advisable.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Corrispondenza: federico.marchetti@auslromagna.it